A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.
This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.
Read Also
- It is possible to get covid-19 after getting vaccinated, this says the CDC May 27, 2021
- 10% of the population vaccinated by September Jun 3, 2021
- Video games help in the pandemic | Atomix Sep 7, 2021
- Covid, Iss: “Most new infections in unvaccinated” Jul 11, 2021
- Finding toilets, an “obstacle course” for people with bowel diseases Nov 23, 2022
- Medicine shortage: Are you worried that you won’t be able to treat yourself properly this winter? Nov 19, 2022
- Plans : those that walk, and our advice to stick to it Jun 18, 2020